Neoleukin Therapeutics, Inc.
NLTX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $71,005 | $58,813 | $70,771 | $136,586 |
| Short-Term Investments | $194,405 | $215,706 | $221,831 | $175,819 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5,109 | $4,467 | $3,796 | $3,518 |
| Total Curr. Assets | $270,519 | $278,986 | $296,398 | $315,923 |
| Property Plant & Equip (Net) | $15,911 | $16,895 | $17,668 | $18,493 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1,402 | $1,435 | $1,235 | $1,314 |
| Total NC Assets | $17,313 | $18,330 | $18,903 | $19,807 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $287,832 | $297,316 | $315,301 | $335,730 |
| Liabilities | – | – | – | – |
| Payables | $1,544 | $2,060 | $3,063 | $1,336 |
| Short-Term Debt | $3,104 | $3,134 | $3,084 | $2,999 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $10,062 | $10,246 | $7,947 | $10,822 |
| Total Curr. Liab. | $14,710 | $15,440 | $14,094 | $15,157 |
| LT Debt | $7,104 | $7,832 | $8,623 | $9,429 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $478 | $789 | $789 | $769 |
| Total NC Liab. | $7,582 | $8,621 | $9,412 | $10,198 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $22,292 | $24,061 | $23,506 | $25,355 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$327,914 | -$306,961 | -$284,945 | -$262,298 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $593,454 | $580,216 | $576,740 | $572,673 |
| Total Equity | $265,540 | $273,255 | $291,795 | $310,375 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $287,832 | $297,316 | $315,301 | $335,730 |
| Net Debt | -$60,797 | -$47,847 | -$59,064 | -$124,158 |